Key Account Manager - Boston, MA
OtherUSAUSD 170K–USD 205K / yearly1 months ago
Company identity and hiring signals verified from public source listings
Observed daily snapshots
Latest: 20 roles
Observed active listings was unchanged from 20 to 20 across 6 snapshot days. Missing days are left as gaps and are not estimated.
| Date | Active listings |
|---|---|
| 2026-09-30 | 20 |
| 2026-10-12 | 20 |
| 2026-10-15 | 20 |
| 2026-10-18 | 20 |
| 2026-10-21 | 20 |
| 2026-10-24 | 20 |
Listing recency
Source observation shows when Base Career last saw listings at their source. It does not mean every listing was revalidated within the last 24 hours.
Based on n=20 classified listings
Based on n=20 classified listings
Based on n=9 classified listings
Based on n=20 classified listings
| Seniority | Median range | Sample |
|---|---|---|
| Manager | USD 170K–USD 205K / yearly | n=10 |
| Senior | USD 170K–USD 205K / yearly | n=8 |
Verified active listings
OtherUSAUSD 170K–USD 205K / yearly1 months ago
OtherUSAUSD 170K–USD 205K / yearly1 months ago
OtherUSAUSD 170K–USD 205K / yearly1 months ago
OtherUSAUSD 170K–USD 205K / yearly1 months ago
OtherUSAUSD 170K–USD 205K / yearly1 months ago
OtherUSAUSD 170K–USD 205K / yearly1 months ago
OtherUSAUSD 170K–USD 205K / yearly1 months ago
OtherUSAUSD 170K–USD 205K / yearly1 months ago
OtherUSAUSD 170K–USD 205K / yearly1 months ago
OtherUSAUSD 170K–USD 205K / yearly1 months ago
OtherHybridNew York CityUSD 170K–USD 250K / yearly6 months ago
OtherLund9 months ago
SalesFieldUnited StatesUSD 170K–USD 205K / yearly
SalesFieldUnited StatesUSD 170K–USD 205K / yearly
SalesFieldUnited StatesUSD 170K–USD 205K / yearly
FinanceHybridNew York City, New York, United StatesUSD 110K–USD 135K / yearly
SalesFieldUnited StatesUSD 170K–USD 205K / yearly
OperationsHybridNew York, New York, United StatesUSD 170K–USD 200K / yearly
FinanceHybridNew York City, New York, United StatesUSD 225K–USD 250K / yearly
LogisticsHybridNew York City, New York, United StatesUSD 215K–USD 250K / yearly
Public Swedish biopharmaceutical company developing and commercializing immunomodulatory treatments for people with rare immunological conditions.